Filter
544
Text search:
variants
Featured
Recommendations
80
New Publications
52
Language
Document type
Guidelines
131
No document type
131
Studies & Reports
115
Fact sheets
56
Strategic & Response Plan
37
Manuals
30
Videos
14
Situation Updates
9
Training Material
7
Resource Platforms
7
Infographics
4
Brochures
3
Countries / Regions
Global
29
Africa
24
Latin America and the Carribbean
18
India
15
Brazil
14
Western and Central Europe
11
Germany
10
Russia
10
Kenya
8
Syria
6
South Africa
6
East and Southern Africa
6
West and Central Africa
6
Middle East and North Africa
6
Nigeria
5
Ethiopia
5
Niger
5
Congo, Democratic Republic of
4
South Sudan
4
Malawi
4
Mozambique
4
Colombia
4
Eastern Europe
4
Senegal
3
Cameroon
3
Haiti
3
Lebanon
3
Peru
3
Bolivia
3
Myanmar / Burma
3
Chile
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Ghana
2
Uganda
2
Philippines
2
Turkey
2
Chad
2
Rwanda
2
Bangladesh
2
Sudan
2
Argentina
2
Ukraine
2
Nicaragua
2
Yemen
2
Kazakhstan
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
China
1
Indonesia
1
Mauritania
1
Benin
1
Central African Republic
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Western Pacific Region
1
Palestine
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
United Kingdom
1
Portugal
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
143
Clinical Guidelines
41
Public Health
30
Key Resources
15
Pharmacy & Technologies
13
Women & Child Health
9
Capacity Building
5
Toolboxes
COVID-19
261
Mental Health
34
HIV
21
Rapid Response
17
NTDs
17
Planetary Health
16
TB
15
AMR
15
NCDs
11
Global Health Education
9
Ebola
7
Conflict
7
Health Financing Toolbox
7
Caregiver
5
Refugee
4
Specific Hazards
4
Pharmacy
4
Cholera
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t
...
Resource platform
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa
...
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés tests de diagnostic rapide, TDR) offre une méthode plus rapide et moins coûteuse pour te
...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi
...
The African Development Bank has launched a consultation process with health ministers and other partners as it develops a strategy to drive enhanced access to health services across Africa through 2030.
Input from ministers in the Bank’s 54 regional member countries, development partners and c
...
La présente Stratégie pour des infrastructures sanitaires de qualité en Afrique2021-2030 (SISQA) répond à une demande des gouverneurs de la Banque africaine de développement (la BAD ou la Banque) invitant l’institution à définir son rôle dans la lutte contre les déficits d’infrastructu
...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
Brazilian media and science communicators must understand the main characteristics of misinformation in social media about COVID-19, so that they can develop attractive, up-to-date and evidence-based content that helps to increase health literacy and counteract the spread of false information.
O Ministério da Saúde atualiza o Diagnosticar para Cuidar com o PLANO NACIONAL DE EXPANSÃO DA TESTAGEM PARA COVID-19 (PNE-Teste) que tem a finalidade de expandir o diagnóstico da covid-19 por meio do teste rápido de antígeno (TR-AG), para uso em indivíduos sintomáticos e assintomáticos, par
...
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
11 august 2022, updated version
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021
SPRP:
1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
